Tag: Health Care/Life Sciences

Pfizer’s next play: A vaccine maker and pandemic ‘partner’ to governments

Pfizer Inc.’s COVID-19 vaccine is on track to generate a whopping $26 billion in sales this year, making it the drug maker’s top-selling drug and...

Opinion: Biotech companies are trying to solve stubborn illnesses using ‘drugs from bugs’

Poor germs. They just can’t catch a break. Many people, not only germaphobes, spend lots of energy trying to avoid germs like, well, the plague....

New York City sets goal to reopen fully on July 1: De Blasio

Mayor Bill de Blasio announced Thursday morning that New York City will set a goal to ‘fully reopen’ on July 1, citing the city’s strong...

The resurgent U.S. economy grew 6.4% in first quarter and even faster growth lies ahead

The numbers: The U.S. economy charged ahead in the first three months of the year thanks to more Americans getting vaccinated, fewer people catching the...

Why comparing blood clot risks from COVID-19 vaccines and birth control pills doesn’t work

In the days since the Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) called for a temporary pause in...

The pandemic’s differing earnings effects will be on display with tech, airline reports

The first big week of earnings season will kick off with a study in contrasts. The tech and airline sectors feature prominently on the earnings...

Tech shares rise but Dow under pressure as U.S. pauses Johnson & Johnson COVID vaccine rollout

U.S. stocks were trading mixed Tuesday morning after U.S. public-health agencies requested a temporary halt in the use of Johnson & Johnson’s one-shot COVID vaccine...

How to pay for healthcare costs in retirement

As retirement risks go, it’s one of the more impossible to manage and mitigate. For years now, firms in the financial services industry, as well...

Oil prices fall as U.S. data show hefty rise in gasoline supplies

Oil prices headed lower on Wednesday, with gasoline futures leading the losses in the sector as traders parsed U.S. government data showing a more-than-3-million-barrel decline...

U.S. COVID vaccine program speeds up to about 3 million doses a day in the past week

The U.S. COVID-19 vaccine program continues to kick into high gear, setting a record Saturday of more than four million doses administered, although experts continue...

Here are the stocks that could benefit from $4 trillion of infrastructure spending, according to Bank of America

President Joe Biden is due to present his infrastructure spending plan on Wednesday, the opening salvo in getting legislation through Congress to fix crumbling roads...

What you need to know about COVID-19 vaccine passports — and the ‘double privilege’ dilemma they raise for society

Neil Schwartzman is used to getting vaccines in order to travel to exotic parts of the world such as the Great Rift Valley of Kenya...

These are the stocks for playing Biden’s infrastructure push, analysts say

President Joe Biden’s big speech on infrastructure is slated to come on Wednesday as he visits Pittsburgh. Analysts have been thinking about his push for...

Dow clings to gain, but tech stocks slide while Beige Book shows only modest economic uptick

U.S. stock benchmarks mostly were lower Wednesday afternoon, as technology shares weighed down the S&P 500 and Nasdaq Composite, after bond yields spiked and weaker-than-expected...

Single dose of AstraZeneca or Pfizer COVID-19 vaccine cuts hospitalization risk by up to 80%, study shows

A single dose of either the AstraZeneca–Oxford vaccine or the Pfizer–BioNTech COVID-19 shot cuts the risk of hospital admission among older adults by more than...

Dr. Fauci on J&J COVID-19 vaccine: ‘I would have no hesitancy whatsoever to take it’

Dr. Anthony Fauci called all three U.S. coronavirus vaccines ‘highly efficacious.’ NBC Dr. Anthony Fauci has urged Americans not to turn their nose up at...

Black Americans are more likely to travel farther to get COVID-19 vaccines

Black Americans in some parts of the country will have to travel farther than their white counterparts to get vaccinated against COVID-19, a new white...

Black Americans are more likely to travel farther to get COVID-19 vaccines

Black Americans in some parts of the country will have to travel farther than their white counterparts to get vaccinated against COVID-19, a new white...

Cannabis stocks rally anew as $7 billion GW Pharma deal spurs interest in weed and its medical benefits

Cannabis stocks rallied anew on Wednesday, spurred on by news of a $7 billion deal for the first company to win U.S. regulatory approval for...

AstraZeneca vaccine may reduce spread by 67% — and protection remains over 3-month dosage gap

A single dose of the AstraZeneca AZN, -0.88% COVID-19 vaccine offers 76% protection for up to three months after the first injection and appears to...

As vaccinations continue, 45% of millennials say they’re OK with socializing in public places

Millennials, who aren’t likely to begin receiving coronavirus vaccines until the summer, are the most comfortable partaking in activities that are considered higher risks for...

As vaccinations continue, 45% of millennials say they’re OK with socializing in public places

Millennials, who aren’t likely to begin receiving coronavirus vaccines until the summer, are the most comfortable partaking in activities that are considered higher risks for...

Here’s what the robot fund that’s beating the S&P 500 is investing in now

Shares of the videogame retailer are up 23% in premarket trading after Monday’s wild session. To some, this is stirring memories of the dot-com boom...

As new coronavirus strains raise questions about mask quality, the N95 market in the U.S. is still facing supply issues

Government officials in the U.S. and Europe have called for stricter mask protocols as more infectious strains of the coronavirus circulate, yet there is still...

Sanofi teams up with BioNTech and Pfizer to help fix Europe’s vaccine shortage

Sanofi SAN, +0.01% will help manufacture millions of doses of the COVID shot developed by rivals BioNTech and Pfizer PFE, +0.08% to help speed up...